The obvious counter to that and (feel free to interject if I'm wrong) is that it's because other countries have instituted price controls on pharmaceuticals that companies have to make up their profits on the US market.

My worry here is that the price control seems to act as a disincentive for selling in the price controlled market. So long as there are 49 other states where margins are greater, it seems like those orders will be fulfilled first.